[HTML][HTML] Cholesterol lowering in intermediate-risk persons without cardiovascular disease

…, K Sliwa, RJG Peters, C Held, I Chazova… - … England Journal of …, 2016 - Mass Medical Soc
Background Previous trials have shown that the use of statins to lower cholesterol reduces
the risk of cardiovascular events among persons without cardiovascular disease. Those trials …

[HTML][HTML] Blood-pressure lowering in intermediate-risk persons without cardiovascular disease

…, LS Piegas, K Keltai, M Keltai, I Chazova… - … England Journal of …, 2016 - Mass Medical Soc
Background Antihypertensive therapy reduces the risk of cardiovascular events among high-risk
persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its …

Pulmonary hypertension due to left heart disease

…, M Guazzi, G Coghlan, I Chazova… - European respiratory …, 2019 - Eur Respiratory Soc
Pulmonary hypertension (PH) is frequent in left heart disease (LHD), as a consequence of
the underlying condition. Significant advances have occurred over the past 5 years since the …

[HTML][HTML] Blood-pressure and cholesterol lowering in persons without cardiovascular disease

…, M Keltai, K Keltai, K Sliwa, I Chazova… - … England Journal of …, 2016 - Mass Medical Soc
Background Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol
increase the risk of cardiovascular disease. Lowering both should reduce the risk of …

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND …

…, J Pogue, E Paolasso, N Holwerda, I Chazova… - The Lancet …, 2011 - thelancet.com
Background Cardiovascular risk factors are associated with dementia and cognitive decline.
We investigated the effects of renin-angiotensin system blockade on cognitive function in …

Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

I Chazova, JE Loyd, VS Zhdanov… - The American journal …, 1995 - ncbi.nlm.nih.gov
Primary pulmonary hypertension (PPH) is associated with a spectrum of structural changes
in the pulmonary arteries: increased medial thickness, eccentric and concentric intimal …

Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin

I Chazova, VA Almazov… - Diabetes, Obesity and …, 2006 - Wiley Online Library
Aim: To compare the effects of moxonidine and metformin on glycaemic control in patients
with impaired glucose tolerance and signs of the metabolic syndrome. Methods: A multicentre, …

Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries

…, L Ceremuzynski, A Budaj, R Ferreira, I Chazova… - Neurology, 2015 - AAN Enterprises
Objective: We sought to determine the association of dietary factors and risk of cognitive
decline in a population at high risk of cardiovascular disease. Methods: Baseline dietary intake …

[HTML][HTML] Improved hypertension control with the imidazoline agonist moxonidine in a multinational metabolic syndrome population: principal results of the MERSY …

I Chazova, MP Schlaich - International journal of hypertension, 2013 - hindawi.com
This study was designed to assess the effects of moxonidine on blood pressure and aspects
of the metabolic syndrome in racially diverse population of patients encountered in routine …

Overweight and obesity in the Russian population: prevalence in adults and association with socioeconomic parameters and cardiovascular risk factors

…, A Conrady, O Rotar, Y Zhernakova, I Chazova… - Obesity facts, 2019 - karger.com
Objective: To evaluate the prevalence and geographic distribution of overweight and obesity
in Russian adults aged 25–64 years as well as the association between chronic risk factors …